CYTK Q2 2018 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+103.6% YoY

Gross Profit

-$15M-247.3% margin

Operating Income

-$23M-376.7% margin

Net Income

-$28M-442.8% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+18.0%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$247M

Total Liabilities

$172M

Stockholders' Equity

$75M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+103.6%
Gross Profit	-$15M	-$17M	+8.3%
Operating Income	-$23M	-$25M	+7.1%
Net Income	-$28M	-$29M	+5.4%

Revenue Segments

License And Service

$2M100%